Cargando…
Active Immunotherapy for Glioblastoma Treatment: A Systematic Review and Meta-Analysis
INTRODUCTION: Glioblastoma multiforme (GBM) makes 60–70% of gliomas and 15% of primary brain tumors. Despite the availability of standard multimodal therapy, 2 years, 3 years, and 5 years survival rate of GBM are still low. Active immunotherapy is a relatively new treatment option for GBM that seems...
Autores principales: | Wahyuhadi, Joni, Immadoel Haq, Irwan Barlian, Arifianto, Muhammad Reza, Sulistyono, Bagus, Meizikri, Rizki, Rosada, Atika, Sigit Prakoeswa, Cita Rosita, Susilo, Rahadian Indarto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950026/ https://www.ncbi.nlm.nih.gov/pubmed/36748348 http://dx.doi.org/10.1177/10732748221079474 |
Ejemplares similares
-
Tranexamic acid to reduce operative blood loss in brain tumor surgery: A meta-analysis
por: Prastikarunia, Resi, et al.
Publicado: (2021) -
Deadly complication of sacrificing superior petrosal vein during cerebellopontine angle tumor resection: A case report and literature review
por: Haq, Irwan Barlian Immadoel, et al.
Publicado: (2021) -
Lifesaving Decompressive Craniectomy for High Intracranial Pressure Attributed to Deep-Seated Meningioma: Emergency Management
por: Haq, Irwan Barlian Immadoel, et al.
Publicado: (2021) -
Remote extradural hematoma as a complication of endoscopic transsphenoidal surgery: A case report with literature review()
por: Destiansyah, Rifqi Aulia, et al.
Publicado: (2022) -
Clear-cell renal cell carcinoma and glioblastoma multiforme coexistence: Double primary malignancy, does it have a causal relationship?
por: Simanjuntak, Kevin Ariel Tiopan, et al.
Publicado: (2022)